Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection
Laura Page, Michael Freemark
Topics & Concepts
LiraglutideMedicineWeight lossPlaceboAdverse effectObesityGlucagon-like peptide 1 receptorAgonistInternal medicineBioinformaticsPharmacologyIntensive care medicineEndocrinologyDiabetes mellitusReceptorType 2 diabetesAlternative medicineBiologyPathologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentNeuropeptides and Animal Physiology